Ahmed Hamdy MD - 29 Jun 2021 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Ahmed M. Hamdy
Issuer symbol
VINC
Transactions as of
29 Jun 2021
Net transactions value
+$99,989
Form type
4
Filing time
30 Jun 2021, 19:02:45 UTC
Next filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $99,989 +7,830 $12.77* 7,830 29 Jun 2021 The Hamdy Family Trust dated 10/7/2015 F1
holding VINC Common Stock 1,618,199 29 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $12.59 to $12.77 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.